Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering

95Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The antibiotic bleomycin, a strong DNA cutting agent, is naturally produced by actinomycetes which have developed a resistance mechanism against such a lethal compound. The crystal structure, at 2.3 Å resolution, of a bleomycin resistance protein of 14 kDa reveals a structure in two halves with the same α/β fold despite no sequence similarity. The crystal packing shows compact dimers with a hydrophobic interface and involved in mutual chain exchange. Two independent solution studies (analytical centrifugation and light scattering) showed that this dimeric form is not a packing artefact but is indeed the functional one. Furthermore, light scattering also showed that one dimer binds two antibiotic molecules as expected. A crevice located at the dimer interface, as well as the results of a site-directed mutagenesis study, led to a model wherein two bleomycin molecules are completely sequestered by one dimer. This provides a novel insight into antibiotic resistance due to drug sequestering, and probably also into drug transport and excretion.

Cite

CITATION STYLE

APA

Dumas, P., Bergdoll, M., Cagnon, C., & Masson, J. M. (1994). Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering. EMBO Journal, 13(11), 2483–2492. https://doi.org/10.1002/j.1460-2075.1994.tb06535.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free